<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05034614</url>
  </required_header>
  <id_info>
    <org_study_id>21-006131</org_study_id>
    <nct_id>NCT05034614</nct_id>
  </id_info>
  <brief_title>Pap Smear Collection With the Papette Brush</brief_title>
  <official_title>Pap Smear Collection With the Papette Brush: A Pragmatic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is comparing Pap smear collection techniques using the Papette brush to&#xD;
      traditional spatula and cytology brush for cervical cancer screening&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      At the investigators institution the investigators have been using both the traditional&#xD;
      spatula and cytology and the Papette brush for Pap smear collection. The investigators will&#xD;
      be comparing adequacy of sample rates, provider perceived pain and bleeding and overall&#xD;
      satisfaction with each collection technique.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 18, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Specimen adequacy</measure>
    <time_frame>Baseline</time_frame>
    <description>Number of samples that have cervical cellular adequacy for a satisfactory evaluation indicated on the cytology report</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cervical bleeding with collection</measure>
    <time_frame>Baseline</time_frame>
    <description>Number of subjects to experience bleeding with collection of samples during the Pap smear exam</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Collection time</measure>
    <time_frame>Baseline</time_frame>
    <description>The amount of time it takes to collect a sample measure in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived pain</measure>
    <time_frame>Baseline</time_frame>
    <description>Provider-reported survey to assess patient perceived pain for Papette brush compare to spatula/cytology bush technic as more, the same, or less patient perceived pain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">706</enrollment>
  <condition>Cervical Cancer Screening</condition>
  <arm_group>
    <arm_group_label>Pap smears using the Papette</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Papette brush used to collect a Pap smear sample as standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pap smears using the traditional spatula/cytology brush</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Spatula/cytology brush used to collect a Pap smear sample as standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Papette brush collection</intervention_name>
    <description>Cervical cell brush that gathers collects cervical cells during Pap smear collection</description>
    <arm_group_label>Pap smears using the Papette</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Spatula/cytology brush collection</intervention_name>
    <description>Combination of extended-tip spatula with endocervical brush that collects cervical cells during Pap smear collection</description>
    <arm_group_label>Pap smears using the traditional spatula/cytology brush</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult women, aged 21-64 years old.&#xD;
&#xD;
          -  Have given consent for medical records to be accessed.&#xD;
&#xD;
          -  Who will have a Pap smear exam in CIM from July 2021 through June 2022.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women, age &lt; 21 or &gt; 64.&#xD;
&#xD;
          -  Has vaginal spotting present during cervical sampling.&#xD;
&#xD;
          -  Did not give consent to have medical records accessed.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danielle O'Laughlin, PA-C, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle J O'Laughlin, PA-C, MS</last_name>
      <phone>507-284-5278</phone>
      <email>olaughlin.danielle@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 30, 2021</study_first_submitted>
  <study_first_submitted_qc>August 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 5, 2021</study_first_posted>
  <last_update_submitted>October 19, 2021</last_update_submitted>
  <last_update_submitted_qc>October 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Danielle J. O'Laughlin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pap Smear Collection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

